Palisade Bio (PALI) Stock Chart & Stock Price History $1.09 -0.15 (-12.10%) Closing price 07/29/2025 04:00 PM EasternExtended Trading$1.08 -0.01 (-0.92%) As of 08:47 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Palisade Bio Stock Price Performance The Palisade Bio (PALI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 68.95%, with a year-to-date return of -33.94%. In the past month, the stock has increased 60.27%, reflecting recent market activity. As of the latest close, Palisade Bio traded at $1.09 with a market cap of $5.23 million and volume of 673,930 shares. Receive PALI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palisade Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.03%1 Month Performance+60.27%3 Month Performance+40.45%Year-To-Date Performance-33.94%1 Year Performance-68.95% PALI Stock Chart for Wednesday, July, 30, 2025 PALI Chart by TradingView Palisade Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/29/2025$1.24$1.09-12.10%$1.35$1.06673,930 shs$5.23 million07/28/2025$1.16$1.24+6.90%$1.40$1.151.66 million shs$5.95 million07/25/2025$1.11$1.16+4.50%$1.29$1.121.51 million shs$5.57 million07/24/2025$1.22$1.11-9.02%$1.15$0.961.37 million shs$5.33 million07/23/2025$0.86$1.22+41.86%$1.36$0.8611.90 million shs$5.85 million07/22/2025$0.95$0.86-9.20%$0.99$0.83526,803 shs$4.13 million07/21/2025$0.75$0.95+26.28%$0.95$0.761.45 million shs$4.55 million07/18/2025$0.75$0.75+0.54%$0.77$0.7548,481 shs$3.60 million07/17/2025$0.75$0.75-0.67%$0.76$0.7263,468 shs$3.58 million07/16/2025$0.75$0.75+0.13%$0.76$0.7327,543 shs$3.61 million Get the Latest News and Ratings for PALI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Palisade Bio and its competitors with MarketBeat's FREE daily newsletter. 07/15/2025$0.76$0.75-1.92%$0.76$0.7368,648 shs$3.60 million07/14/2025$0.75$0.76+1.55%$0.79$0.7558,293 shs$3.67 million07/11/2025$0.78$0.75-3.46%$0.79$0.75120,011 shs$3.61 million07/10/2025$0.76$0.78+2.63%$0.79$0.7677,565 shs$3.74 million07/09/2025$0.72$0.76+5.41%$0.76$0.72138,686 shs$3.65 million07/08/2025$0.73$0.72-1.77%$0.75$0.70179,425 shs$3.46 million07/07/2025$0.73$0.73+1.24%$0.76$0.7219,207 shs$3.52 million07/04/2025$0.73$0.73$0.73$0.7027,836 shs$3.48 million07/03/2025$0.73$0.73-0.62%$0.73$0.7027,836 shs$3.48 million07/02/2025$0.72$0.73+2.01%$0.77$0.70118,881 shs$3.50 million07/01/2025$0.68$0.72+5.15%$0.73$0.7092,079 shs$3.43 million06/30/2025$0.70$0.68-2.84%$0.70$0.6673,571 shs$3.26 million Related Companies LEXX Stock Price Chart VYNE Stock Price Chart GELS Stock Price Chart ATHA Stock Price Chart HOTH Stock Price Chart MRKR Stock Price Chart DRRX Stock Price Chart EDSA Stock Price Chart PASG Stock Price Chart LPCN Stock Price Chart Receive PALI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palisade Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PALI) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredSmall Cap- AI Hospitals = Big OpportunityA tiny NASDAQ firm just launched a generative AI platform aimed at disrupting a $2 trillion healthcare market....Smallcaps Daily | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palisade Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palisade Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
